Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lundbeck presents innovative first in human trial design of Lu AG13909 for potential treatment of congenital adrenal hyperplasia

Lundbeck is to showcase innovative trial design at ENDO 2024 of the first in human trial of Lu AG13909 for congenital adrenal hyperplasia (CAH), a rare debilitating disease with excess morbidity and mortality.H. Lundbeck A/S (Lundbeck) will present the novel design of the first in human trial of Lu AG13909, a potential first-in-class treatment for CAH, at ENDO in Boston. The presentation will take place on 3 June 2024, at 12:00 (noon) EDT. The poster is to be presented by trial investigator Dr. Srirangalingam Umasuthan, University College London Hospitals, London, UK, who said: “We

Relais Group Plc - Managers' transactions - Seppänen

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Seppänen, Sebastian Position: Other senior manager Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603093003_15 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name:

Relais Group Plc - Managers' transactions - Popov

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Popov, Jan Position: Other senior manager Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603093003_16 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name: Option

Relais Group Plc - Managers' transactions - Mikkonen

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Mikkonen, Ville Position: Other senior manager Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603093003_17 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name:

Relais Group Plc - Managers' transactions - Ekström

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Ekström, Thomas Position: Chief Financial Officer Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603093003_14 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name:

Relais Group Plc - Managers' transactions - Ekholm

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Ekholm, Arni Position: Chief Executive Officer Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603093003_13 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name:

Relais Group Plc - Managers' transactions - Ekholm

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Ekholm, Arni Position: Chief Executive Officer Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603092858_10 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name:

Outcome reached in the collective labour agreement negotiations at UPM Raflatac

(UPM, Helsinki, Finland, 3 June 2024 at 15:00 EEST) – UPM Raflatac and the Paper Workers' Union have reached an outcome in the collective labour agreement negotiations concerning UPM Raflatac’s Tampere factory in Finland. "The negotiations were conducted in a very good spirit and constructively from start to finish. I would like to thank the Paper Workers’ Union for its solution-oriented approach and for the good negotiations. The solution will enable the long-term development of the Tampere factory," says Antti Waajakoski, General Manager of UPM Raflatac’s Tampere factory. The new

Getinge introduces Poladus 150 – the future of low-temperature sterilization

Today, Getinge unveils the Poladus 150, its latest innovation in low-temperature sterilization, designed for heat-sensitive surgical instruments. Equipped with advanced cross-contamination barrier technology, Poladus 150 plays a crucial role in preventing healthcare acquired infections (HCAIs). Getinge’s new Vaporized Hydrogen Peroxide (VH2O2) low-temp sterilizer Poladus 150 operates within a gentle temperature of up to 55°C, ensuring that non-lumen, flexible lumen, and rigid lumen instruments are ready for the next surgery. “Today marks a significant milestone for our

Cessatech announces superior simulated pain efficacy in children favouring its lead candidate CT001 relative to its active comparators.

·The simulated pain reduction in NRS in children using CT001 was -87%, compared to -52%, -32% and +10% for sufentanil, ketamine and placebo respectively.  ·Estimates for the opioid sparing effect of ketamine showed a need for more than double the sufentanil exposure to get the same overall effect seen with the treatment of CT001.  ·The data supports the earlier reported data from the Dental Study 0205 showing the effectiveness of treatment with CT001. The full simulated data set will be presented at the PAGE conference in Rome 26-28 June.On 3 June – Cessatech A/S (“Cessatech”

Addtech acquires Nuova Elettromeccanica Sud S.p.A.

Addtech Energy, a business area in the Addtech Group, has today signed an agreement to acquire 100 % of the shares outstanding in Nuova Elettromeccanica Sud S.p.A. (”NES”). NES develops, manufactures and sells equipment and components for electric transmission lines and substations. The company has long been established as a supplier to grid operators, primarily in Europe. NES has 60 employees and a turnover of approximately EUR 14 million and is headquartered in Rome, Italy. NES further develops our position as a global supplier of high-voltage transmission equipment and complements

Vestas receives a 124 MW order in Lithuania

News release from Vestas Northern and Central EuropeHamburg, 3 June 2024 Vestas has received a 124 MW order for a wind energy project in Telsiai in Lithuania. Vestas will deliver 20 V162-6.2 MW wind turbines, and the order includes supply, delivery, and commissioning of the turbines. The order was placed by Utilitas Wind and Latvenergo AS. Upon completion, Vestas will service the turbines throughout their life cycle under an Active Output Management 5000 (AOM 5000) service agreement designed to ensure optimised performance of the assets. Utilitas Wind and Latvenergo AS have

Successful EdmoLift Convention and 60th Anniversary

This weekend, EdmoLift celebrated its 60th anniversary with a grand convention that brought together customers, employees, suppliers, and partners from around the world. We want to extend a heartfelt thank you to everyone who attended, participated, and contributed to making the event an unforgettable experience.The convention, which began on Friday, was held at the headquarters in Härnösand. Throughout the day, guests had the opportunity to learn about EdmoLift's history and the latest developments within the company. Additionally, they listened to inspiring speeches on topics such as AI

Akobo Minerals Annual report 2023

OSLO, 31 May 2024: Akobo Minerals AB  Reference is made to the financial calendar published on 13 May 2024, where the Company scheduled the publication of its consolidated financial statements for 2023 today, 31 May 2024. The Company hereby announces that it is unable to publish its consolidated financial statements as scheduled today, and that it has applied to the Oslo Stock Exchange (Nw: "Oslo Børs") for an extension of up to 14 days, until 14 June 2024, to disclose the financial statements for 2023. The delay is due to late receipt of necessary information from the Company's

Borr Drilling Limited – 2024 Annual General Meeting date

Borr Drilling Limited (NYSE and OSE: BORR) advises that the 2024 Annual General Meeting will be held on August 14, 2024. The record date for voting at the Annual General Meeting is set to June 7, 2024. The notice, agenda and associated material will be distributed prior to the meeting. Hamilton, Bermuda June 3, 2024 This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Humana completes the acquisition of Team Olivia Norge AS

Humana has completed the acquisition of Team Olivia Norge AS. The acquisition is expected to contribute to lower operational risk through a more diversified customer base and broader geographical exposure.After the Norwegian Competition Authority, as previously communicated, approved the acquisition of Team Olivia Norge AS, the acquisition has been completed. The purchase price is financed with million SEK 236 from existing cash and an issue in kind of ordinary shares to Team Olivia AB (the “Seller”), resolved by the Board based on authorisation from the annual general meeting held 9 May

Hexagon Composites ASA - Sale of Hexagon Ragasco to Worthington Enterprises completed

3 June 2024: Hexagon Composites (HEX.OL) is pleased to announce that the sale of Hexagon Ragasco to Worthington Enterprises announced 29 May 2024 was closed today.  For more information: Karen Romer, SVP Communications, Hexagon Composites ASA Telephone: +47 950 74 950 | karen.romer@hexagongroup.com Ingrid Aarsnes, VP Investor Relations and ESG, Hexagon Composites ASA Telephone: +47 950 38 364 | ingrid.aarsnes@hexagongroup.com   About Hexagon Composites Hexagon Composites (OSE: HEX.OL) is a world leader in composite cylinder technology and related systems that delivers safe

Audientes A/S and SensoDetect AB Announce Strategic Collaboration to Enhance Mental and Hearing Health Solutions in Saudi Arabia and Beyond

Press release no. 01-2024June 3, 2024June 3, 2024 - Copenhagen, Denmark - Audientes A/S (“Audientes”), an innovative Danish manufacturer of affordable, self-fitting hearing aids and hearables, and SensoDetect AB (“SensoDetect”), a pioneering Swedish company in mental health diagnostics including observations in ADHD, schizophrenia, and autism assessments, are pleased to announce a strategic collaboration to advance mental and hearing health solutions, with an initial focus on the Saudi Arabian market and plans for expansion across the Middle East and North Africa (MENA).   This

First steps taken to integrate CST-Assistant training with the formal CST-education in DK – a key market gateway milestone, also paving way for the UK

Copenhagen, Denmark, 3 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP)  ·Under the CO-PI granted project, Brain+ has held the first CST-Assistant training sessions to test the integration of the product with the formal CST education in Denmark   ·The objective is to establish a new CST-education standard, which includes in depth introduction to and hands-on training in the CST-Assistant to facilitate an easier transition from education to CST practice   ·Educating new CST therapists based on the CST-Assistant is an important gateway for greater customer reach and a

Total Voting Rights

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 3 June 2024 ZIGUP PLC - Total Voting Rights   The following notification is made in accordance with Rule 5.6 of the FCA's Disclosure Guidance and Transparency Rules. As at 3 June 2024, ZIGUP PLC confirms that its share capital consists of 246,091,423 ordinary shares of 50p each, of which 19,914,362 ordinary shares are held in treasury, and 1,000,000

Watch all videos from BioStock Global Forum 2024

On May 29-30, BioStock hosted the Global Forum. The event is the first of its kind, aimed at bringing together growth stage Nordic life science companies looking to expand into new markets and experts armed with a profound knowledge of how business is done across the globe. Check out the highlights from the event here!Watch all videos from Global Forum at biostock.se: https://www.biostock.se/2024/06/biostock-global-forum-2024/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Betolar Plc: Mikko Wirkkala appointed as CFO of Betolar Plc

Betolar Plc  Company Release 3 June 2024 at 12:10 PM EEST   Betolar Plc: Mikko Wirkkala appointed as CFO of Betolar Plc Mikko Wirkkala (M.Sc. Econ.) has been appointed as company’s new Chief Financial Officer and a member of the Management Team. He will start in his position no later than 3 September 2024 and will report to CEO Tuija Kalpala. Riikka Ylikoski, the company's current CFO, will continue in her current role until mid-July. In the interim, Soila Söderström, the company’s General Counsel and a member of the Management Team, will undertake the additional

Storykit adds unique AI-powered transcription and subtitling functionality: “An unbeatable way to build your brand”

Add “talking heads” to your video content without all the hassle of transcribing, editing and subtitling the clip. It’s possible, with Storykit’s new AI functionality. “Bringing real people into your videos is often key to success on social, but there hasn’t been a simple way to do it. So we built it”, says Peder Bonnier, CEO at Storykit.In a time where relationships and authenticity play a significant role in the success of your communication, “talking head” clips, where one or more people are talking, have become increasingly popular. However, due to the importance of subtitles in videos,

There are no items matching the current filter
There are no more items matching the current filter
Back to top